Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stereotactic Body Radiation Therapy (SBRT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05132790
What this trial is testing

Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Shengjing Hospital 24
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Testing effectiveness (Phase 2)UnknownNCT02545751
What this trial is testing

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerStereotactic Body Radiation Therapy+1 more
Hangzhou Cancer Hospital 29
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Testing effectiveness (Phase 2)UnknownNCT06088056
What this trial is testing

A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesRadiotherapy
Fudan University 17
Testing effectiveness (Phase 2)UnknownNCT06422156
What this trial is testing

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Peking University Third Hospital 73
Not applicableEnded earlyNCT01799135
What this trial is testing

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Dana-Farber Cancer Institute 6
Not applicableUnknownNCT03529708
What this trial is testing

Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression

Who this might be right for
Spinal Cord CompressionCauda Equina SyndromeStereotactic Body Radiotherapy
Juravinski Cancer Center 30
Not applicableLooking for participantsNCT06560697
What this trial is testing

Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma

Who this might be right for
Uterine Cervical Neoplasm
National Institute of Cancerología 84
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Not applicableWithdrawnNCT04069910
What this trial is testing

Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases

Who this might be right for
Malignant Neoplasm, BrainBrain Tumor
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00832780
What this trial is testing

Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung

Who this might be right for
Lung CancerNon Small Cell Lung CancerSolid Tumors
New Mexico Cancer Research Alliance 44
Testing effectiveness (Phase 2)UnknownNCT04089150
What this trial is testing

MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease

Who this might be right for
Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 120
Not applicableUnknownNCT01764646
What this trial is testing

Hypofractionated Radiation Therapy in Prostate Cancer

Who this might be right for
Malignant Neoplasm of ProstateLocal Disease
Thomas Zilli 170
Testing effectiveness (Phase 2)Looking for participantsNCT06835725
What this trial is testing

Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CA
British Columbia Cancer Agency 100
Not applicableActive Not RecruitingNCT04273893
What this trial is testing

Lymphocyte Depletion and Change in Lymphocyte Functionality

Who this might be right for
Lymphocyte Depletion
University of Virginia 55
Not applicableStudy completedNCT00941915
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 60
Testing effectiveness (Phase 2)Study completedNCT05133440
What this trial is testing

Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 12
Not applicableStudy completedNCT02704143
What this trial is testing

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 63
Testing effectiveness (Phase 2)Looking for participantsNCT06775743
What this trial is testing

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University 53
Next Page